Could islet transplantation be a potential cure for diabetes?

Area of Science:

• Endocrinology
• Transplantation immunology

Background:

• Type 1 diabetes involves autoimmune destruction of insulin-producing beta cells.
• Current management relies on exogenous insulin, which has limitations.
• Islet transplantation offers a potential alternative by restoring endogenous insulin production.

Purpose of the Study:

• To explain the process of islet transplantation.
• To provide a realistic outlook on the clinical program's expected outcomes.
• To inform patients and clinicians about this emerging treatment.

Main Methods:

• Islet isolation from donor pancreases.
• Infusion of isolated islets into the portal vein of recipients.
• Immunosuppression to prevent graft rejection.

Main Results:

• Successful engraftment and insulin production by transplanted islets.
• Reduction or elimination of exogenous insulin requirements.
• Variable graft survival and function over time.

Conclusions:

• Islet transplantation is a viable therapeutic option for select patients with type 1 diabetes.
• The clinical program aims to improve patient outcomes and quality of life.
• Ongoing research focuses on enhancing graft survival and reducing immunosuppression.